About
Epidutech is Introducing a novel technology platform for spine navigation surgeries that will revolutionize the navigation market. The technology is a unique AI-Powered magnet-based technology. The invaluable technology platform harness the power of AI to overcome a complex inverse magnetic physical problem resulting in a groundbreaking technology platform, compact, affordable, accurate, and enables to expand the usage of navigation to more procedures.
The company harness the power of AI to overcome a complex inverse magnetic physical problem resulting in a groundbreaking technology platform that will revolutionize the navigation market: Navigation during spine surgery plays a vital role in achieving positive outcomes, and lowering complications. yet the usage is limited [20%]. Epidutech vision is to bridge the gap with our New Gen Navigation Platform and introduce a Less Invasive, Compact, Precise and Affordable system across hospitals, clinics and Ambulatory Surgery Centers [ASCs].
Funding history · 1 round · $870K total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Epidutech's primary focus?
- Epidutech is developing a novel AI-powered magnetic navigation platform for spine surgeries.
- When was Epidutech founded?
- Epidutech was founded in December 2019.
- Where is Epidutech headquartered?
- Epidutech is headquartered in Caesarea, Israel.
- What is the total amount of funding Epidutech has raised?
- Epidutech has raised a total of $870,000 USD.
- Which investor participated in Epidutech's seed round?
- NGT3 participated in Epidutech's seed funding round in December 2019.
- What is Epidutech's current employee count?
- Epidutech currently has 5 employees.
- What markets does Epidutech target geographically?
- Epidutech targets North America, Europe, and global markets.
- What is the product stage of Epidutech's technology?
- Epidutech's product is currently in the R&D stage.
- Does Epidutech hold any patents?
- Yes, Epidutech holds 1 patent.